Brief: ALX Oncology Q3 Basic EPS USD -0.58
07/11/2024 21:00
Nov 07 (Reuters) - ALX Oncology Q3 income from operations USD -32.567 million. * Q3 net income USD -30.707 million * Q3 operating expenses USD 32.567 million
Recent news on ALX Oncology Holdings
See all newsALX Oncology Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
ALX Oncology Holdings Inc expected to post a loss of 15 cents a share - Earnings Preview
ALX Oncology Q2 net loss narrows on lower R&D costs
Brief: ALX Oncology Q2 Basic EPS USD -0.13
Brief: Alx Oncology Holdings - Enters Loan And Security Agreement With HSBC Ventures On June 25, 2026 - SEC Filing